Related Experiment Video
Updated: Dec 11, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design
Vera H Buss1,2, Alison Shield2, Sam Kosari2
1Centre for Primary Health Care and Equity, University of New South Wales, Randwick, Australia.
International Journal of Clinical Pharmacy
|August 18, 2020
Summary
Community pharmacists find the MedsCheck program beneficial for improving patient understanding and adherence to medications. However, barriers like staffing and patient awareness hinder its optimal delivery and integration with broader healthcare services.
Area of Science:
- Pharmacy Practice
- Health Services Research
Background:
- MedsCheck is an Australian Government-funded in-pharmacy medication review program.
- The program aims to enhance patient comprehension of medicines and address adherence challenges.
Purpose of the Study:
- To investigate community pharmacists' perspectives on the MedsCheck program.
- Focus areas include perceived effectiveness, delivery barriers, and service integration.
Main Methods:
- A mixed-method triangulation design combining semi-structured interviews and a national online survey.
- Thematic analysis of qualitative data and quantitative analysis of survey responses.
Main Results:
- Pharmacists perceive MedsCheck as beneficial for patients, with 76% agreeing it improves patient outcomes.
- Key barriers identified include insufficient staffing, lack of patient awareness, and limited integration with general practitioner services.
- Communication of review outcomes to GPs was infrequent (53% rarely or never reported).
Conclusions:
- Community pharmacists view MedsCheck as a valuable tool for medication management and patient education.
- Addressing barriers such as workload, patient engagement, and interprofessional collaboration is crucial for maximizing the program's effectiveness.
- Improved integration could enhance pharmacist engagement with patients and GPs, ultimately improving medication understanding and adherence.
Related Concept Videos
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
01:20Measurement of Bioavailability: Pharmacodynamic Methods
115
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
115
01:12Analysis of Population Pharmacokinetic Data
585
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
585
01:28Dosage Regimens: Designs and Approaches
168
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
168
01:26Drug Administration and Therapy Phases: Overview
1.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.0K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
78
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
78